FNY Investment Advisers’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-190,000
| Closed | -$514K | – | 1037 |
|
2021
Q1 | $514K | Sell |
190,000
-10,000
| -5% | -$27.1K | 0.19% | 101 |
|
2020
Q4 | $484K | Hold |
200,000
| – | – | 0.13% | 137 |
|
2020
Q3 | $458K | Sell |
200,000
-100,000
| -33% | -$229K | 0.19% | 112 |
|
2020
Q2 | $690K | Hold |
300,000
| – | – | 0.4% | 64 |
|
2020
Q1 | $516K | Buy |
300,000
+25,000
| +9% | +$43K | 0.39% | 61 |
|
2019
Q4 | $569K | Buy |
275,000
+22,000
| +9% | +$45.5K | 0.18% | 88 |
|
2019
Q3 | $733K | Buy |
253,000
+118,600
| +88% | +$344K | 0.22% | 61 |
|
2019
Q2 | $526K | Buy |
+134,400
| New | +$526K | 0.16% | 83 |
|